| The role of epigenetics in the biology of multiple myeloma K Dimopoulos, P Gimsing, K Grønbæk Blood cancer journal 4 (5), e207-e207, 2014 | 152 | 2014 |
| Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon‐independent manner K Dimopoulos, A Søgaard Helbo, H Fibiger Munch‐Petersen, L Sjö, ... Molecular oncology 12 (2), 180-195, 2018 | 80 | 2018 |
| Aberrant micro RNA expression in multiple myeloma K Dimopoulos, P Gimsing, K Grønbæk European journal of haematology 91 (2), 95-105, 2013 | 72 | 2013 |
| Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma LS Kristensen, F Asmar, K Dimopoulos, MK Nygaard, D Aslan, ... Oncotarget 5 (20), 9798, 2014 | 41 | 2014 |
| Expression of CRBN, IKZF1, and IKZF3 does not predict lenalidomide sensitivity and mutations in the cereblon pathway are infrequent in multiple myeloma K Dimopoulos, H Fibiger Munch-Petersen, C Winther Eskelund, ... Leukemia & lymphoma 60 (1), 180-188, 2019 | 33 | 2019 |
| Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations D Aslan, C Garde, MK Nygaard, AS Helbo, K Dimopoulos, JW Hansen, ... Oncotarget 7 (9), 9951, 2016 | 33 | 2016 |
| Epigenetic therapy in hematological cancers K Dimopoulos, K Grønbæk Apmis 127 (5), 316-328, 2019 | 28 | 2019 |
| Detailed Long‐Term Follow‐Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3 CW Eskelund, K Dimopoulos, A Kolstad, I Glimelius, R Räty, ... Hemasphere 5 (1), e510, 2021 | 24 | 2021 |
| TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy HD Munch-Petersen, F Asmar, K Dimopoulos, A Areškevičiūtė, P Brown, ... Acta neuropathologica communications 4, 1-13, 2016 | 24 | 2016 |
| Genome-wide circular RNA expression patterns reflect resistance to immunomodulatory drugs in multiple myeloma cells T Jakobsen, M Dahl, K Dimopoulos, K Grønbæk, J Kjems, LS Kristensen Cancers 13 (3), 365, 2021 | 22 | 2021 |
| Hypermethylation of the VTRNA1-3 Promoter is Associated with Poor Outcome in Lower Risk Myelodysplastic Syndrome Patients A Søgaard Helbo, M Treppendahl, D Aslan, K Dimopoulos, ... Genes 6 (4), 977-990, 2015 | 21 | 2015 |
| The diagnostic and prognostic role of flow cytometry in idiopathic and clonal cytopenia of undetermined significance (ICUS/CCUS): A single‐center analysis of 79 patients K Dimopoulos, OK Hansen, LD Sjö, L Saft, IM Schjødt, J Werner Hansen, ... Cytometry Part B: Clinical Cytometry 98 (3), 250-258, 2020 | 9 | 2020 |
| Structural aberrations are associated with poor survival in patients with clonal cytopenia of undetermined significance SU Mikkelsen, S Safavi, K Dimopoulos, CJ O’Rourke, MK Andersen, ... haematologica 106 (6), 1762, 2021 | 8 | 2021 |
| Inflammatory cytokine profiles do not differ between patients with idiopathic cytopenias of undetermined significance and myelodysplastic syndromes AB Nielsen, JW Hansen, AD Ørskov, K Dimopoulos, M Salem, ... Hemasphere 6 (5), e0713, 2022 | 6 | 2022 |
| Diagnosis of thrombotic thrombocytopenic purpura by ADAMTS13 activity quantification K Dimopoulos, M Philips, JP Goetze The Journal of Applied Laboratory Medicine 7 (3), 637-649, 2022 | 5 | 2022 |
| Comprehensive and unbiased multiparameter high-throughput screening by compaRe finds effective and subtle drug responses in AML models MC Hajkarim, E Karjalainen, M Osipovitch, K Dimopoulos, SL Gordon, ... Elife 11, 2022 | 3 | 2022 |
| Laboratory investigation and diagnosis of thrombotic thrombocytopenic purpura K Dimopoulos, A Tripodi, JP Goetze Critical Reviews in Clinical Laboratory Sciences 60 (8), 625-639, 2023 | 2 | 2023 |
| Concurrent inhibition of akt and ERK using TIC-10 can overcome venetoclax resistance in mantle cell lymphoma AM Granau, PA Andersen, T Jakobsen, K Taouxi, N Dalila, JB Mogensen, ... Cancers 15 (2), 510, 2023 | 1 | 2023 |
| ProGraME: A novel flow cytometry algorithm for the diagnosis of low‐risk myelodysplastic syndromes in patients with cytopenia J Therkelsen, DW Træden, I Schjødt, MK Andersen, LD Sjö, JW Hansen, ... European Journal of Haematology 111 (6), 851-862, 2023 | | 2023 |
| Measurement of amyloid-β 1–42 in cerebrospinal fluid: a comparison of the second generation Elecsys and INNOTEST K Dimopoulos, AH Simonsen, MH Gramkow, M Schrøder, NR Jørgensen, ... Clinical Chemistry and Laboratory Medicine (CCLM) 61 (9), e182-e185, 2023 | | 2023 |
